Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Phase I/II Study in Patients With Dysphonia and Vocal Fold Scarring to Evaluate Safety, Tolerability and Vocal Function After Surgery With Local Administration of Autologous Mesenchymal Stromal Cells

NCT04290182 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT04290182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04290182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Phase I/II Study in Patients With Dysphonia and Vocal Fold Scarring to Evaluate Safety, Tolerability and Vocal Function After Surgery With Local Administration of Autologous Mesenchymal Stromal Cells
Lead sponsor
Karolinska University Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
March 1, 2021
Completion date
January 1, 2025
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aphonia, dysphonia, hoarseness, vocal fold scar